Hyderabad-based active pharmaceutical ingredients (APIs) and drug intermediates' maker Divis Laboratories Limited has reported a 68.9 per cent increase in net profit at Rs 379.49 crore for the quarter ended December 2018 as compared to Rs 224.66 crore in the corresponding quarter of the previous year.
Total revenue grew 30.58 per cent to Rs 1,377.48 crore during the quarter under review as compared to Rs 1,054.89 crore in the year-ago period.
Big increase in net profit comes on the back of higher growth in revenue and the profit margins as compared to its performance in corresponding period of the previous quarter.